A Phase I Trial of Weekly and Every Three Weeks Ixabepilone and Sunitinib in Solid Tumor Patients.
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2016
At a glance
- Drugs Ixabepilone (Primary) ; Sunitinib
- Indications Solid tumours
- Focus Adverse reactions
- 28 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Feb 2014 Planned End Date changed from 1 Nov 2013 to 1 Nov 2015 as reported by ClinicalTrials.gov.
- 28 Feb 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.